CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,944,255 | -29.2% | 679,577 | -18.6% | 0.02% | -28.6% |
| Q2 2023 | $11,222,508 | -24.8% | 835,008 | -7.2% | 0.04% | -34.0% |
| Q1 2023 | $14,919,065 | -9.8% | 899,823 | +1.2% | 0.05% | -10.2% |
| Q4 2022 | $16,545,295 | +63.8% | 889,532 | +13.0% | 0.06% | +25.5% |
| Q3 2022 | $10,098,000 | +372.5% | 787,100 | +158.2% | 0.05% | +422.2% |
| Q2 2022 | $2,137,000 | +0.7% | 304,800 | +19.0% | 0.01% | +28.6% |
| Q1 2022 | $2,123,000 | -20.2% | 256,100 | -34.8% | 0.01% | -22.2% |
| Q4 2021 | $2,660,000 | +64.1% | 392,900 | +28.4% | 0.01% | +50.0% |
| Q3 2021 | $1,621,000 | -7.8% | 305,900 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,759,000 | +4.8% | 305,900 | -16.0% | 0.01% | -14.3% |
| Q1 2021 | $1,679,000 | -49.4% | 364,227 | -63.3% | 0.01% | -53.3% |
| Q4 2020 | $3,318,000 | -1.6% | 993,562 | -12.5% | 0.02% | +15.4% |
| Q3 2020 | $3,371,000 | -30.5% | 1,135,062 | +8.1% | 0.01% | -45.8% |
| Q2 2020 | $4,850,000 | +1063.1% | 1,049,735 | +869.3% | 0.02% | +700.0% |
| Q1 2020 | $417,000 | +50.5% | 108,300 | +46.7% | 0.00% | +200.0% |
| Q4 2019 | $277,000 | – | 73,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |